Clinical Trial Update: Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

View source ↗

Summary

A prospective registry update for the decellularized femoral artery allograft (Nexeon AVX) enrolling patients with End-Stage Renal Disease; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: LifeNet Health | Conditions: End-Stage Renal Disease | Status: RECRUITING